Ennetbaden, Switzerland

Christina Claus

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 7.4

ph-index = 6

Forward Citations = 115(Granted Patents)


Location History:

  • Schlieren, CH (2020 - 2022)
  • Ennetbaden, CH (2019 - 2024)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):

Title: The Innovative Contributions of Inventor Christina Claus

Introduction

Christina Claus is a remarkable inventor based in Ennetbaden, Switzerland, known for her significant contributions to the field of biomedical innovation. With an impressive portfolio of 12 patents, Claus has made strides in developing therapies that target critical cancer receptors, showcasing the intersection of medicine and cutting-edge science.

Latest Patents

Among her latest patents, Christina's invention titled "Combination therapy with targeted 4-1BB (CD137) agonists" focuses on employing these agonists in various combination therapies, especially in conjunction with HER-2 targeting agents. This innovation aims to improve cancer treatment outcomes by enhancing the efficacy of existing therapies. Moreover, her patent for "Bispecific antibodies specific for OX40" introduces novel bispecific antigen-binding molecules designed to interact with target cell antigens and members of the TNF receptor family. This invention not only emphasizes her prowess in antibody design but also opens avenues for advanced therapeutic strategies in oncology.

Career Highlights

Currently, Christina Claus is an integral part of Hoffmann-La Roche Inc., where she plays a pivotal role in the development of innovative therapeutic solutions. Her career is marked by a dedication to advancing cancer treatment methodologies through her innovative research and patent contributions. Her work has been instrumental in positioning her as a leading figure in her field.

Collaborations

Throughout her career, Christina has collaborated with numerous esteemed professionals, including colleagues Claudia Ferrara Koller and Christian Klein. These collaborations have further enriched her research, fostering an environment of shared knowledge and innovation that is essential for breakthroughs in biomedical applications.

Conclusion

Christina Claus exemplifies the spirit of innovation and dedication to improving cancer treatment through her inventive mind and collaborative efforts. Her patented technologies and contributions to biomedical research mark her as a significant inventor whose work continues to resonate within the scientific community, ultimately enhancing patient care and treatment outcomes in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…